Search results for "psychotropic drugs"

showing 10 items of 53 documents

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects

2004

The advent of psychotherapeutic drugs has enabled management of mental illness and other neurological problems such as epilepsy in the general population, without requiring hospitalization. The success of these drugs in controlling symptoms has led to their widespread use in the vulnerable population of pregnant women as well, where the potential embryotoxicity of the drugs has to be weighed against the potential problems of the maternal neurological state. This review focuses on the developmental toxicity and neurotoxicity of five broad categories of widely available psychotherapeutic drugs: the neuroleptics, the antiepileptics, the antidepressants, the anxiolytics and mood stabilizers, an…

Drugmedicine.medical_specialtymedia_common.quotation_subjectPopulationDevelopmental toxicityserotonin-reuptake inhibitorsEpilepsyNeurochemicalmedicineAnimalsHumansprenatal phenytoin exposurePsychiatryeducationbeta-adrenergic-receptorsmedia_commonPharmacologyrat-brain developmentPsychotropic Drugseducation.field_of_studybusiness.industryMental DisordersNeurotoxicityBrainbeta-adrenergic-receptors; central-nervous-system; cerebellar granule cells; developing cerebral-cortex; fetal hydantoin syndrome; messenger-rna expression; prenatal phenytoin exposure; rat-brain development; serotonin-reuptake inhibitors; st-johns-wortmedicine.diseaseMental illnessdeveloping cerebral-cortexmessenger-rna expressionMoodcerebellar granule cellsMolecular Medicinecentral-nervous-systemPlant Preparationsst-johns-wortfetal hydantoin syndromebusiness
researchProduct

Sensitive Screening of New Psychoactive Substances in Serum Using Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.

2021

Abstract Analysis of new psychoactive substances (NPS) still poses a challenge for many institutions due to the number of available substances and the constantly changing drug market. Both new and well-known substances keep appearing and disappearing on the market, making it hard to adapt analytical methods in a timely manner. In this study we developed a qualitative screening approach for serum samples by means of liquid chromatography--quadrupole time-of-flight mass spectrometry. Samples were measured in data-dependent auto tandem mass spectrometry mode and identified by fragment spectra comparison, retention time and accurate mass. Approximately 500 NPS, including 195 synthetic cannabino…

Health Toxicology and MutagenesisToxicologyMass spectrometry01 natural sciencesMethcathinoneAnalytical Chemistry03 medical and health sciencesBenzodiazepines0302 clinical medicineTandem Mass SpectrometrySynthetic cannabinoidsmedicineEnvironmental Chemistry030216 legal & forensic medicineSolid phase extractionQuadrupole time of flightPsychotropic DrugsChemical Health and SafetyChromatographyChemistryElution010401 analytical chemistryReproducibility of ResultsSerum samples0104 chemical sciencesSubstance Abuse DetectionRetention timemedicine.drugChromatography LiquidJournal of analytical toxicology
researchProduct

The Peptide Hemopressin Acts through CB1Cannabinoid Receptors to Reduce Food Intake in Rats and Mice

2010

Hemopressin is a short, nine amino acid peptide (H-Pro-Val-Asn-Phe-Lys-Leu-Leu-Ser-His-OH) isolated from rat brain that behaves as an inverse agonist at the cannabinoid receptor CB1, and is shown here to inhibit agonist-induced receptor internalization in a heterologous cell model. Since this peptide occurs naturally in the rodent brain, we determined its effect on appetite, an established central target of cannabinoid signaling. Hemopressin dose-dependently decreases night-time food intake in normal male rats and mice, as well as in obeseob/obmale mice, when administered centrally or systemically, without causing any obvious adverse side effects. The normal, behavioral satiety sequence is …

LeptinMaleTime FactorsCannabinoid receptormedicine.medical_treatmentPharmacologyRats Sprague-DawleyEatingHemoglobinsMicechemistry.chemical_compoundPiperidinesReceptor Cannabinoid CB1RimonabantChlorocebus aethiopsDronabinolReceptorMice KnockoutBehavior AnimalDrug Administration RoutesGeneral NeuroscienceArticlesEndocannabinoid systemCircadian RhythmProtein TransportCOS CellsRimonabantmedicine.drugAgonistmedicine.medical_specialtymedicine.drug_classMorpholinesGreen Fluorescent ProteinsDrinking BehaviorHyperphagiaNaphthalenesBiologyTransfectionInternal medicinemedicineAnimalsInverse agonistAnalysis of VariancePsychotropic DrugsDose-Response Relationship DrugCyclohexanolsPeptide FragmentsHemopressinBenzoxazinesRatsMice Inbred C57BLEndocrinologychemistryPyrazolesCannabinoidFood DeprivationThe Journal of Neuroscience
researchProduct

Unexpected identification and characterization of a cathinone precursor in the new psychoactive substance market: 3',4'-methylenedioxy-2,2-dibromobut…

2019

Abstract 3′,4′-methylenedioxy-2,2-dibromobutyrophenone has been identified and fully characterized in a sample obtained from an anonymous consumer acquired as ketamine through the Internet market. The substance has been deeply characterized by using standard and high performance analytical techniques such as: attenuated total reflectance-infrared spectroscopy, gas chromatography–mass spectrometry, high-resolution mass spectrometry, elemental analysis, and nuclear magnetic resonance, including 1H, 13C, distortionless enhancement by polarization transfer, two dimensional homonuclear 1H-1H correlation spectroscopy, and 1H-13C heteronuclear single-quantum correlation spectra. 3′,4′-methylenedio…

Magnetic Resonance SpectroscopyCathinonePyrovaleroneMass spectrometry01 natural sciencesMethylenedioxyGas Chromatography-Mass SpectrometryPathology and Forensic MedicineDesigner Drugs03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAlkaloidsSpectroscopy Fourier Transform InfraredmedicineOrganic chemistryHumans030216 legal & forensic medicineInternetPsychotropic DrugsIllicit Drugs010401 analytical chemistryButyrophenones0104 chemical sciencesHeteronuclear moleculechemistryCounterfeit DrugsPentyloneAmine gas treatingKetamineLawTwo-dimensional nuclear magnetic resonance spectroscopymedicine.drugChromatography LiquidForensic science international
researchProduct

Effects of tetrahydrocannabinol on glucose uptake in the rat brain

2017

Δ9-Tetrahydrocannabinol (THC) is the psychoactive component of the plant Cannabis sativa and acts as a partial agonist at cannabinoid type 1 and type 2 receptors in the brain. The goal of this study was to assess the effect of THC on the cerebral glucose uptake in the rat brain. 21 male Sprague Dawley rats (12-13 w) were examined and received five different doses of THC ranging from 0.01 to 1 mg/kg. For data acquisition a Focus 120 small animal PET scanner was used and 24.1-28.0 MBq of [18F]-fluoro-2-deoxy-d-glucose were injected. The data were acquired for 70 min and arterial blood samples were collected throughout the scan. THC, THC-OH and THC-COOH were determined at 55 min p.i. Nine volu…

Male0301 basic medicineCannabinoid receptormedicine.medical_treatmentGlucose uptakeStimulationPharmacologyPartial agonistRats Sprague-Dawley03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineFluorodeoxyglucose F18Tandem Mass Spectrometrymental disordersmedicineAnimalsDronabinolTetrahydrocannabinolCannabinoid Receptor AgonistsPharmacologyBrain MappingPsychotropic DrugsDose-Response Relationship DrugChemistryorganic chemicalsBrainGlucose030104 developmental biologyPositron-Emission TomographyCerebellar cortexArterial bloodCannabinoidRadiopharmaceuticals030217 neurology & neurosurgeryChromatography Liquidmedicine.drugNeuropharmacology
researchProduct

Studies on the reliability of a bihyperbolic functional absorption model. II. Phenylalkylamines

1987

Evidence is given that demonstrates the reliability of the bihyperbolic equation, proposed by Pla-Delfina and Moreno, in fitting the correlation between absorption rate constants (ka) found in the small intestine and in the colon of the living anesthetized rat, and partition constants (1/R.F−1), for a series of phenylalkylamines, a group of compounds which differ largely from others which have been tested. Emphasis is laid on the nonexistence of an optimum of lipophilicity for intestinal absorption/partition correlation: This feature makes inapplicable the probabilistic approaches to the reported data.

MaleBenzylaminesPsychotropic DrugsAniline CompoundsPropylaminesSeries (mathematics)ChemistryStereochemistryThermodynamicsRats Inbred StrainsButylaminesModels BiologicalIntestinal absorptionRatsAbsorption rateIntestinal AbsorptionColonic absorptionPhenethylaminesLipophilicityAnimalsPartition (number theory)Pharmacology (medical)General Pharmacology Toxicology and PharmaceuticsAbsorption (chemistry)Reliability (statistics)Journal of Pharmacokinetics and Biopharmaceutics
researchProduct

Comparative pharmacological activity of optical isomers of phenibut

2007

Phenibut (3-phenyl-4-aminobutyric acid) is a GABA (gamma-aminobutyric acid)-mimetic psychotropic drug which is clinically used in its racemic form. The aim of the present study was to compare the effects of racemic phenibut and its optical isomers in pharmacological tests and GABAB receptor binding studies. In pharmacological tests of locomotor activity, antidepressant and pain effects, S-phenibut was inactive in doses up to 500 mg/kg. In contrast, R-phenibut turned out to be two times more potent than racemic phenibut in most of the tests. In the forced swimming test, at a dose of 100 mg/kg only R-phenibut significantly decreased immobility time. Both R-phenibut and racemic phenibut showed…

MaleHot TemperaturePhenibutMotor ActivityPharmacologyGABAB receptorConflict PsychologicalGABA AntagonistsMicechemistry.chemical_compoundOrganophosphorus CompoundsReaction TimemedicineAnimalsMuscle StrengthGABA AgonistsPostural BalanceSwimminggamma-Aminobutyric AcidPain MeasurementPharmacologyAnalgesicsMice Inbred ICRPsychotropic DrugsDepressionAntagonistStereoisomerismBiological activityAntidepressive AgentsPsychotropic drugBaclofenReceptors GABA-BchemistryMice Inbred CBAEnantiomerPsychomotor Performancemedicine.drugBehavioural despair testEuropean Journal of Pharmacology
researchProduct

Understanding Cannabinoid Psychoactivity with Mouse Genetic Models

2007

Marijuana and its main psychotropic ingredient Δ9-tetrahydrocannabinol (THC) exert a plethora of psychoactive effects through the activation of the neuronal cannabinoid receptor type 1 (CB1), which is expressed by different neuronal subpopulations in the central nervous system. The exact neuroanatomical substrates underlying each effect of THC are, however, not known. We tested locomotor, hypothermic, analgesic, and cataleptic effects of THC in conditional knockout mouse lines, which lack the expression of CB1 in different neuronal subpopulations, including principal brain neurons, GABAergic neurons (those that release γ aminobutyric acid), cortical glutamatergic neurons, and neurons expres…

MaleMESH: Body TemperatureCannabinoid receptormedicine.medical_treatmentGene ExpressionMESH: Receptor Cannabinoid CB1NeocortexMESH: gamma-Aminobutyric AcidMESH: CatalepsyPharmacologyHippocampusMESH: Mice KnockoutMESH: Corpus StriatumBody TemperatureMESH: Autonomic Nervous SystemMESH: NeocortexMice0302 clinical medicineReceptor Cannabinoid CB1MESH: Behavior AnimalCannabinoid receptor type 1MESH: AnimalsMESH: Gene SilencingDronabinolMESH: NociceptorsBiology (General)gamma-Aminobutyric AcidMice Knockout0303 health sciencesBehavior Animalmusculoskeletal neural and ocular physiologyGeneral NeuroscienceMESH: Pain ThresholdNociceptorsMESH: Glutamic AcidMESH: InterneuronsMESH: Motor Activity3. Good healthGABAergicMESH: TetrahydrocannabinolGeneral Agricultural and Biological SciencesResearch Articlemedicine.drugPain ThresholdMESH: Gene ExpressionMESH: Psychotropic DrugsQH301-705.5Glutamic AcidMotor ActivityBiologyAutonomic Nervous SystemGeneral Biochemistry Genetics and Molecular Biologygamma-Aminobutyric acid03 medical and health sciencesGlutamatergicDopamine receptor D1InterneuronsCannabinoid Receptor Modulatorsmental disorders[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologymedicineAnimalsGenetic Predisposition to Disease[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyGene SilencingTetrahydrocannabinolMESH: MiceAnesthesiology and Pain Management030304 developmental biologyPharmacologyCatalepsyPsychotropic DrugsModels GeneticGeneral Immunology and MicrobiologyCannabinoidsIllicit Drugsorganic chemicalsMESH: MaleCorpus StriatumPrimerDisease Models Animalnervous systemCannabinoidNervous System Diseases030217 neurology & neurosurgeryNeurosciencePLoS Biology
researchProduct

Physical and cognitive doping in university students using the unrelated question model (UQM): Assessing the influence of the probability of receivin…

2018

Study objectives: In order to increase the value of randomized response techniques (RRTs) as tools for studying sensitive issues, the present study investigated whether the prevalence estimate for a sensitive item π̂$_{s}$ assessed with the unrelated questionnaire method (UQM) is influenced by changing the probability of receiving the sensitive question p. Material and methods: A short paper-and-pencil questionnaire was distributed to 1.243 university students assessing the 12-month prevalence of physical and cognitive doping using two versions of the UQM with different probabilities for receiving the sensitive question (p ≈ 1/3 and p ≈ 2/3). Likelihood ratio tests were used to assess wheth…

MaleQuestionnairesPeptide Hormoneslcsh:MedicineSocial SciencesBiochemistryMathematical and Statistical Techniques0504 sociologySociologySurveys and QuestionnairesStatisticsPrevalenceMedicine and Health SciencesHuman Performanceddc:796lcsh:ScienceMathematicsDoping in SportsMultidisciplinarySocial ResearchOrganic Compounds05 social sciencesDrugsCognitionMiddle AgedChemistryAthletic & outdoor sports & gamesNeurologyResearch DesignBehavioral PharmacologyPhysical SciencesFemaleSteroidsResearch ArticleAdultAdolescentUniversitiesSubstance-Related DisordersStreet drugsBayesian MethodResearch and Analysis Methods050105 experimental psychologyYoung AdultNeuropharmacologySensitive questionRecreational Drug UseHumans0501 psychology and cognitive sciencesStudentsErythropoietinPharmacologyPsychotropic DrugsBehaviorModels StatisticalSurvey ResearchIllicit Drugslcsh:RAmphetaminesOrganic ChemistryChemical CompoundsCorrection050401 social sciences methodsBiology and Life SciencesHormonesSample size determinationlcsh:QPLoS ONE
researchProduct

Effect of recurrent yohimbine on immediate and post-hoc behaviors, stress hormones, and energy homeostatic parameters

2013

Evidence from experimental models has suggested that acute activation of brain stress and anxiety pathways impacts subsequent behaviors that are mediated or modulated by limbic circuitry. There have been limited investigations of prior or chronic activation of these pathways on subsequent limbic-mediated behaviors. In this study, we tested whether recurrent administration of the anxiogenic compound yohimbine (YOH) could have post-injection effects on brain activation, stress hormones, and performance in sucrose self-administration and startle response paradigms. Rats received six injections across two weeks of either 2mg/kg YOH or saline. Behavioral evaluation confirmed the continued effica…

MaleReflex Startlemedicine.medical_specialtyStartle responseHippocampusExperimental and Cognitive PsychologyAdrenocorticotropic hormoneMotor ActivityAmygdalaArticleEatingBehavioral Neurosciencechemistry.chemical_compoundAdrenocorticotropic HormoneDietary SucroseCorticosteroneInternal medicinemedicineAnimalsPsychotropic Drugsmedicine.diagnostic_testBody WeightBrainYohimbineFeeding BehaviorImmunohistochemistryRatsYohimbineVentral tegmental areamedicine.anatomical_structureEndocrinologyAnxiogenicchemistryCorticosteronePsychologyProto-Oncogene Proteins c-fosStress Psychologicalmedicine.drugPhysiology & Behavior
researchProduct